norfloxacin has been researched along with glutamic acid in 6 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (16.67) | 18.2507 |
| 2000's | 3 (50.00) | 29.6817 |
| 2010's | 2 (33.33) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
| Chen, C; Liu, X; Wu, R | 1 |
| Deguchi, T; Fukuda, H; Ishihara, S; Kawada, Y; Yasuda, M; Yokoi, S | 1 |
| Couet, W; Ebinger, G; Gousseau, C; Marchand, S; Michotte, Y; Smolders, I | 1 |
| Chenel, M; Couet, W; Limosin, A; Marchand, S; Mimoz, O; Paquereau, J | 1 |
| Aloisio, C; Garnero, C; Gracia-Vásquez, S; Longhi, M; Ponce-Ponte, M; Romero-Guerra, DM | 1 |
6 other study(ies) available for norfloxacin and glutamic acid
| Article | Year |
|---|---|
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
High-performance liquid chromatographic method for the determination of norfloxacin glutamate and glucuronate in solid and liquid dosage forms and its application to stability testing.
Topics: Chemistry, Pharmaceutical; Chromatography, High Pressure Liquid; Dosage Forms; Drug Stability; Glucuronates; Glucuronic Acid; Glutamates; Glutamic Acid; Hydrogen-Ion Concentration; Norfloxacin; Reference Standards; Spectrophotometry, Ultraviolet; Temperature | 1993 |
In vitro selection of fluoroquinolone-resistant Neisseria gonorrhoeae harboring alterations in DNA gyrase and topoisomerase IV.
Topics: Anti-Infective Agents; Aspartic Acid; Ciprofloxacin; DNA Gyrase; DNA Topoisomerase IV; DNA Topoisomerases, Type II; DNA, Bacterial; Drug Resistance, Microbial; Escherichia coli; Genes, Bacterial; Glutamic Acid; Humans; Microbial Sensitivity Tests; Mutation; Neisseria gonorrhoeae; Norfloxacin; Ofloxacin; Selection, Genetic; Serine | 2000 |
Convulsant and subconvulsant doses of norfloxacin in the presence and absence of biphenylacetic acid alter extracellular hippocampal glutamate but not gamma-aminobutyric acid levels in conscious rats.
Topics: Administration, Oral; Animals; Anti-Infective Agents; Anti-Inflammatory Agents, Non-Steroidal; gamma-Aminobutyric Acid; Glutamic Acid; Hippocampus; Infusions, Intravenous; Male; Norfloxacin; Phenylacetates; Rats; Rats, Wistar | 2002 |
Norfloxacin-induced electroencephalogram alteration and seizures in rats are not triggered by enhanced levels of intracerebral glutamate.
Topics: Animals; Anti-Infective Agents; Area Under Curve; Brain Chemistry; Electroencephalography; Glutamic Acid; Hippocampus; Male; Microdialysis; Norfloxacin; Rats; Rats, Sprague-Dawley; Seizures | 2003 |
Binary and ternary complexes of norfloxacin to improve the solubility of the active pharmaceutical ingredient.
Topics: 2-Hydroxypropyl-beta-cyclodextrin; Anti-Bacterial Agents; beta-Cyclodextrins; Biological Availability; Calorimetry, Differential Scanning; Chemistry, Pharmaceutical; Drug Carriers; Drug Compounding; Drug Liberation; Freeze Drying; Glutamic Acid; Norfloxacin; Solubility | 2018 |